Tag: opioid withdrawals

  • Opioids Improved Her Life, But Withdrawals Were Hell

    Opioids Improved Her Life, But Withdrawals Were Hell

    “I was afraid. I knew these drugs were heroin in another form. But after I started, I instantly regretted having waited so long.”

    By the time Madora Pennington was 13, she was living with extreme pain. Pennington was born with Ehlers-Danlos syndrome, a painful genetic disorder that left her suicidal by the time she was 20.

    Although she knew about the dangers of powerful prescription opioids, she felt she had no other option that could improve her quality of life.

    “Instead of following through with suicide plans, I spoke with my doctor, who prescribed me opiates,” Pennington wrote for The Los Angeles Times. She began taking Vicodin, morphine and a muscle relaxant every night.

    “I was afraid. I knew these drugs were heroin in another form,” she wrote. “But after I started, I instantly regretted having waited so long.”

    Living With Less Pain

    The opioids allowed Pennington to live with much less pain. For the first time, she was able to make progress in physical therapy, because her body had space to heal. Still, she recognized the powerful allure of the drugs. 

    “At night, when I took my tiny pills, I was transported to a realm where there are no problems. It felt so fake, so obviously chemically induced, but deeply soothing, nonetheless,” Pennington wrote. 

    Her doctor had warned her that she may never be able to quit morphine once she started. However, Pennington told herself that she would do anything she could to get off opioids once her pain and symptoms were under control. When she had the chance, she did just that. 

    “Per the medical definition, I was not an addict. I was never drug-seeking, never doctor shopping, never secretly taking more than I said, never taking for emotional relief. I reduced my intake as my Ehlers-Danlos improved,” she wrote.

    Time To Taper

    Her pharmacist warned her to taper her opioids extremely slowly. Still, Pennington felt unprepared for the physical and emotional symptoms she experienced as she worked to reduce her opioid intake.

    “In a life filled with pain, even I never knew such anguish could exist,” she explained. She was experiencing extreme stomach pain, emotional outbursts and jitters. “I stopped titrating and parked my dose where it was, too sick to go lower,” Pennington wrote.

    When Philip Seymour Hoffman left rehab and fatally overdosed in 2014, Pennington says she understood. 

    A doctor suggested that Pennington stay on low-dose opioids forever, but “that made me furious,” she wrote. “I wanted to be free.”

    She decided to start tapering again, as quickly as she could handle. “I stopped trying to get anything done and steeled myself for the unending agony,” she wrote.

    In 2014, Pennington was officially free from opioids. She had reached her goal and felt great physically, but writes that “the empty low was indescribable.”

    Low-Dose Naltrexone Became A Viable Option

    Finally, she was able to connect with a provider who gave her low-dose naltrexone to help ease the residual effects of opioid withdrawal. Now, she shares her experience on her website to highlight both the importance and dangerous power of opioids.

    “As someone born genetically destined to suffer, I don’t quibble over hypotheticals,” Pennington writes. “It’s no one’s fault that chronic pain is so difficult to treat. I wish I’d had better advice for opiate recovery. I wish I could have gotten to my life now sooner, where I enjoy getting up every day and doing what I want. But I made it here because of the relief I got from opiates. Yes, it was worth it.”

    View the original article at thefix.com

  • Anti-Diarrhea Medication Abuse Continues To Skyrocket

    Anti-Diarrhea Medication Abuse Continues To Skyrocket

    Cases of loperamide exposure are up 90% over a five-year period.

    People who are trying to avoid opioid withdrawals or get a high are more frequently turning to an over-the-counter diarrhea medication, leading to an increase in overdoses from the drug. 

    Researchers from Rutgers University found that overdoses from loperamide—known as “the poor man’s methadone” and sold under the brand name Imodium AD—increased steeply between 2011 and 2016, although they remained very rare, with only 26 cases reported, according to the study published in the journal Clinical Toxicology. At the same time, calls to poison control about the drug rose more than 90%.

    Despite the relatively low numbers, the trend caused alarm for people who see loperamide as an opioid that is easy to access and hard to detect in drug tests.

    Diane Calello, executive and medical director of the New Jersey Poison Control Center at Rutgers New Jersey Medical School and lead study author, said in a news release that loperamide is safe when taken as instructed.

    However, some opioid users take up to 50 times the recommended dosage, at which point the drug becomes very dangerous.  

    “When used appropriately, loperamide is a safe and effective treatment for diarrhea—but when misused in large doses, it is more toxic to the heart than other opioids which are classified under federal policy as controlled dangerous substances,” she said. “Overdose deaths occur not because patients stop breathing, as with other opioids, but due to irregular heartbeat and cardiac arrest.”

    Calello said that over the past years there have been multiple deaths related to loperamide in New Jersey. Because of this, Calello and others recommend that there be changes to the way that loperamide is sold, as well as more public awareness about the risks of the drug. 

    She said, “Possible ways of restricting loperamide misuse include limiting the daily or monthly amount an individual could purchase, requiring retailers to keep personal information about customers, requiring photo identification for purchase and placing medication behind the counter. Most importantly, consumers need to understand the very real danger of taking this medication in excessive doses.”

    In May 2018, the Food and Drug Administration announced changes to the way that loperamide is packaged and sold. FDA head Scott Gottlieb requested that online retailers stop selling large quantities of the drug, and that it be packaged in blister packs, which require users to individually open each pill. These requirements could curb misuse, while also keeping the drug available to people with digestive issues who need it regularly. 

    “We’re very mindful of balancing benefit and risk and the needs of patients in our mission to promote and protect public health,” Gottlieb wrote.

    “The FDA’s actions to address drug misuse and abuse must be informed by an understanding of the complex social environment in which changing patterns of drug consumption occur. The agency is committed to addressing emerging issues of abuse and misuse while taking steps to safeguard the needs of patients who depend on these medicines.”

    View the original article at thefix.com

  • Treatment Clinic Beat The Odds To Help Patients During Hurricane Florence

    Treatment Clinic Beat The Odds To Help Patients During Hurricane Florence

    “Some of those nurses were without power, they sustained damage to their homes, but they showed up every day.”

    When Hurricane Florence swept through the middle of the country, it left behind patients in treatment without access to their possibly life-saving medications.

    The hurricane brought with it flooding and blocked roads and bridges—putting patients in addiction treatment who use methadone or buprenorphine at risk of withdrawal or worse, relapse.

    One opioid addiction clinic, the Carolina Treatment Center, worked beyond its means to provide care for the stranded and desperate coming in from far and wide.

    The clinic would have been in dire straits if the nurses working there—most of them severely and personally affected by the hurricane—had not been able to show up.

    The clinic’s head nurse Kristen Morales worked 16 days in a row while living at a nearby hotel to ensure she could show up for her job. Huffington Post interviewed the treatment center director, Louis Leake, as he worked cases from as far off as Louisiana.

    “We can do a lot of things, but we can’t do a lot of things without nurses,” Leake said. “Some of those nurses were without power, they sustained damage to their homes, but they showed up every day.”

    Past studies have shown the toll that intense storms take on the community of addiction recovery. One study published in Substance Use Misuse, on Hurricane Sandy, concluded that among other troubling findings (such as the increase of shared use of needles) 70% of those in opioid maintenance therapy could not obtain sufficient doses to remain off of opioids.

    The town of Fayetteville’s clinic was closed for a mandatory three-day evacuation. Patients were given between three and six days of treatment medication to take home, after which they had to be resupplied.

    The Carolina Treatment Center was outside of the evacuation zone and took in all of Fayetteville’s addiction treatment patients, to treat a total of more than 900 patients.

    Despite the four days of medication that patients could take home, between the three-day evacuation and road closures and flooding, many patients would have had to suffer through withdrawal or relapse if the Carolina Treatment Center had not gone above and beyond to provide a safety net for this vulnerable community.

    Patient Teri Cooper told The Huffington Post, “It was busy, but thank God I could come here. I guess I would have got some damn drugs, to be honest. [if the clinic were closed] If I didn’t feel good. That’s the truth.”

    View the original article at thefix.com